BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3679084)

  • 1. [Studies on HLA specificities in molar conceptions].
    Shinkai N
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):596-604. PubMed ID: 3679084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HLA and molar pregnancies (triploidies, hydatidiform moles and choriocarcinoma). Etiological and epidemiological study].
    Couillin P; Ravisé N; Afoutou JM; Chaïbi R; Azoulay M; Hors J; Oury JF; Boué J; Boué A
    Ann Genet; 1987; 30(4):197-208. PubMed ID: 3501264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant potential of homozygous and heterozygous complete moles.
    Wake N; Seki T; Fujita H; Okubo H; Sakai K; Okuyama K; Hayashi H; Shiina Y; Sato H; Kuroda M
    Cancer Res; 1984 Mar; 44(3):1226-30. PubMed ID: 6318983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].
    Wake N
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):21-7. PubMed ID: 6325316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human lymphocyte antigen expression in hydatidiform mole: androgenesis following fertilization by a haploid sperm.
    Yamashita K; Wake N; Araki T; Ichinoe K; Makoto K
    Am J Obstet Gynecol; 1979 Nov; 135(5):597-600. PubMed ID: 92196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenetic study of complete and partial hydatidiform mole by HLA (author's transl)].
    Honda J; Sato E; Ihara S; Munakata S; Sugawara N; Fukushima T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):83-8. PubMed ID: 7061896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The propensity to malignancy of dispermic, heterozygous moles].
    Hashimoto M
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):564-72. PubMed ID: 2960601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of human leukocyte antigen G expression in hydatidiform moles.
    Goldman-Wohl D; Ariel I; Greenfield C; Hochner-Celnikier D; Lavy Y; Yagel S
    Am J Obstet Gynecol; 2001 Aug; 185(2):476-80. PubMed ID: 11518912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The propensity to malignant changes in heterozygous moles].
    Seki T; Fujita H; Okubo H; Shiina Y; Wake N; Ichinoe K; Kuroda M; Satoh H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2221-8. PubMed ID: 7153599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunobiology of molar pregnancy and gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Hoch EJ; Anderson DJ
    J Reprod Med; 1984 Nov; 29(11):796-801. PubMed ID: 6097683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MHC class I antigen expression by molar trophoblast].
    Sasagawa M; Yamada K; Fujita K; Shiota A; Sasaki T; Hirokawa M; Yamazaki T; Kurose T; Ohno M; Hando T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1277-83. PubMed ID: 2230405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2--Genetics.
    Fisher RA; Paradinas FJ; Soteriou BA; Foskett M; Newlands ES
    J Pathol; 1997 Feb; 181(2):189-95. PubMed ID: 9120724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
    J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunobiology of vesicular mole and choriocarcinoma].
    Mangili G; Illeni MT; Spolti N; Lombardo C; Bruno L; Maggi R
    Ann Ostet Ginecol Med Perinat; 1990; 111(5):326-31. PubMed ID: 2092608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgenetic origin of African complete hydatidiform moles demonstrated by HLA markers.
    Couillin P; Afoutou JM; Faye O; Ravisé N; Correa P; Boué A
    Hum Genet; 1985; 71(2):113-6. PubMed ID: 3862646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial recurrent hydatidiform mole: a review.
    Fisher RA; Hodges MD; Newlands ES
    J Reprod Med; 2004 Aug; 49(8):595-601. PubMed ID: 15457849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The propensity to malignancy of dispermic heterozygous moles.
    Wake N; Fujino T; Hoshi S; Shinkai N; Sakai K; Kato H; Hashimoto M; Yasuda T; Yamada H; Ichinoe K
    Placenta; 1987; 8(3):319-26. PubMed ID: 2821529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydatidiform mole and HLA. II. Compatibility between patient and conceptus.
    Hansen HE; Vejerslev LO; Larsen SO
    Tissue Antigens; 1988 Sep; 32(3):155-61. PubMed ID: 2851196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome and cellular origin of choriocarcinoma.
    Wake N; Tanaka K; Chapman V; Matsui S; Sandberg AA
    Cancer Res; 1981 Aug; 41(8):3137-43. PubMed ID: 7195772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twin pregnancies with diploid hydatidiform mole and co-existing normal fetus may originate from one oocyte.
    Niemann I; Bolund L; Sunde L
    Hum Reprod; 2008 Sep; 23(9):2031-5. PubMed ID: 18556678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.